Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications

被引：15
|
作者：
Dumbrava, Ecaterina Ileana [1 ]
Alfattal, Rash A. [1 ]
Miller, Vincent A. [2 ]
Tsimberidou, Apostolia Maria [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Fdn Med, Cambridge, MA USA
来源：
JCO PRECISION ONCOLOGY | 2018年 / 2卷
关键词：
ADVANCED SOLID TUMORS; GENETIC ALTERATIONS; DOSE-ESCALATION; PHASE-I; AZD4547; FUSIONS; TARGET; SAFETY; ROLES;
D O I：
10.1200/PO.18.00100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [31] Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?
    Chapman, Christopher H.
    Saba, Nabil F.
    Yom, Sue S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (04)
  • [32] Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma
    Ch'ng, Sydney
    Low, Irene
    Ng, Daniel
    Brasch, Helen
    Sullivan, Michael
    Davis, Paul
    Tan, Swee T.
    HUMAN PATHOLOGY, 2008, 39 (03) : 344 - 349
  • [33] Prognostic Significance of Epidermal Growth Factor Receptor Phosphorylation and Mutation in Head and Neck Squamous Cell Carcinoma
    Hama, Takanori
    Yuza, Yuki
    Saito, Yoshimichi
    O-Uchi, Jin
    Kondo, Shu
    Okabe, Masataka
    Yamada, Hisashi
    Kato, Takakuni
    Moriyama, Hiroshi
    Kurihara, Satoshi
    Urashima, Mitsuyoshi
    ONCOLOGIST, 2009, 14 (09): : 900 - 908
  • [34] HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells
    Hah, J. Hun
    Zhao, Mei
    Pickering, Curtis R.
    Frederick, Mitchell J.
    Andrews, Genevieve A.
    Jasser, Samar A.
    Fooshee, David R.
    Milas, Zvonimir L.
    Galer, Chad
    Sano, Daisuke
    William, William N., Jr.
    Kim, Edward
    Heymach, John
    Byers, Lauren A.
    Papadimitrakopoulou, Vali
    Myers, Jeffrey N.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (11): : 1547 - 1554
  • [35] FGF-targeted chemosensitization of head and neck squamous cell carcinoma
    Wobb, Jessica
    Araki, Koji
    Xu, Le
    Li, Daqing
    O'Malley, Bert
    CANCER RESEARCH, 2009, 69
  • [36] Erratum to: Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck
    D. Rades
    N.D. Seibold
    M.P. Gebhard
    F. Noack
    K.L. Bruchhage
    S.E. Schild
    Strahlentherapie und Onkologie, 2014, 190 : 323 - 323
  • [37] Vascular endothelial growth factor expression in head and neck squamous cell carcinoma
    Eisma, RJ
    Spiro, JD
    Kreutzer, DL
    AMERICAN JOURNAL OF SURGERY, 1997, 174 (05): : 513 - 517
  • [38] Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma
    Dumitru, Cristina-Stefania
    Raica, Marius
    ANTICANCER RESEARCH, 2023, 43 (10) : 4315 - 4326
  • [39] Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
    Till Sebastian Clauditz
    Arne Böttcher
    Henning Hanken
    Kerstin Borgmann
    Guido Sauter
    Waldemar Wilczak
    Tobias Grob
    Adrian Münscher
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 53 - 61
  • [40] Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
    Clauditz, Till Sebastian
    Boettcher, Arne
    Hanken, Henning
    Borgmann, Kerstin
    Sauter, Guido
    Wilczak, Waldemar
    Grob, Tobias
    Muenscher, Adrian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (01) : 53 - 61
12345